Pharnext SCA
OTC:PNEXF

Watchlist Manager

Pharnext SCA

OTC:PNEXF

Watchlist

Dividends

Discount Rate

Price: 999 999.9999 USD Market Closed

Market Cap: 6T USD

Have any thoughts about
Pharnext SCA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 999999.9999 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PNEXF Alert

Pharnext SCA

999999.9999

0.0000 (0%)

52 Week Range	999 999.9999 999 999.9999
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Pharnext SCA

What unique competitive advantages
does Pharnext SCA hold over its rivals?

What risks and challenges
does Pharnext SCA face in the near future?

Provide an overview of the primary business activities
of Pharnext SCA.

What are the Revenue projections
for Pharnext SCA?

Provide an overview of the primary business activities
of Pharnext SCA.

What unique competitive advantages
does Pharnext SCA hold over its rivals?

What risks and challenges
does Pharnext SCA face in the near future?

Has there been any significant insider trading activity
in Pharnext SCA recently?

Show all valuation multiples
for Pharnext SCA.

Provide P/S
for Pharnext SCA.

Provide P/E
for Pharnext SCA.

Provide P/OCF
for Pharnext SCA.

Provide P/FCFE
for Pharnext SCA.

Provide P/B
for Pharnext SCA.

Provide EV/S
for Pharnext SCA.

Provide EV/GP
for Pharnext SCA.

Provide EV/EBITDA
for Pharnext SCA.

Provide EV/EBIT
for Pharnext SCA.

Provide EV/OCF
for Pharnext SCA.

Provide EV/FCFF
for Pharnext SCA.

Provide EV/IC
for Pharnext SCA.

What are the Revenue projections
for Pharnext SCA?

How accurate were the past Revenue estimates
for Pharnext SCA?

What are the Net Income projections
for Pharnext SCA?

How accurate were the past Net Income estimates
for Pharnext SCA?

What are the EPS projections
for Pharnext SCA?

How accurate were the past EPS estimates
for Pharnext SCA?

What are the EBIT projections
for Pharnext SCA?

How accurate were the past EBIT estimates
for Pharnext SCA?

Compare the revenue forecasts
for Pharnext SCA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharnext SCA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharnext SCA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharnext SCA compared to its peers.

Compare the P/E ratios
of Pharnext SCA against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharnext SCA with its peers.

Analyze the financial leverage
of Pharnext SCA compared to its main competitors.

Show all profitability ratios
for Pharnext SCA.

Provide ROE
for Pharnext SCA.

Provide ROA
for Pharnext SCA.

Provide ROIC
for Pharnext SCA.

Provide ROCE
for Pharnext SCA.

Provide Gross Margin
for Pharnext SCA.

Provide Operating Margin
for Pharnext SCA.

Provide Net Margin
for Pharnext SCA.

Provide FCF Margin
for Pharnext SCA.

Show all solvency ratios
for Pharnext SCA.

Provide D/E Ratio
for Pharnext SCA.

Provide D/A Ratio
for Pharnext SCA.

Provide Interest Coverage Ratio
for Pharnext SCA.

Provide Altman Z-Score Ratio
for Pharnext SCA.

Provide Quick Ratio
for Pharnext SCA.

Provide Current Ratio
for Pharnext SCA.

Provide Cash Ratio
for Pharnext SCA.

What is the historical Revenue growth
over the last 5 years for Pharnext SCA?

What is the historical Net Income growth
over the last 5 years for Pharnext SCA?

What is the current Free Cash Flow
of Pharnext SCA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharnext SCA.

P/E
Price to Earnings

-181 004.1

Current

-173 743.6

Median

22.7

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

-181 004.1

Market Cap

6T USD

Net Income

-31.6m EUR

All Countries

Forward Multiples

			Market Cap	P/E
FR		Pharnext SCA OTC:PNEXF	6T USD	-181 004.1
US		Abbvie Inc NYSE:ABBV	312.7B USD	61.5
US		Amgen Inc NASDAQ:AMGN	158.3B USD	37.4
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	115.9B USD	-241.6
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	891.9
US	E	Epizyme Inc F:EPE	94.1B EUR	-472
AU		CSL Ltd ASX:CSL	133.6B AUD	32.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.6B USD	17.8
US	S	Seagen Inc F:SGT	39.3B EUR	-54.6
NL		argenx SE XBRU:ARGX	34.5B EUR	-129.9
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	31.6B USD	-95

				Earnings Growth
FR		Pharnext SCA OTC:PNEXF	Average P/E: 208.3 Negative Multiple: -181 004.1	N/A
US		Abbvie Inc NYSE:ABBV	61.5	412%
US		Amgen Inc NASDAQ:AMGN	37.4	73%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -241.6	42%
US		Gilead Sciences Inc NASDAQ:GILD	891.9	75%
US	E	Epizyme Inc F:EPE	Negative Multiple: -472	N/A
AU		CSL Ltd ASX:CSL	32.9	65%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	17.8	43%
US	S	Seagen Inc F:SGT	Negative Multiple: -54.6	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -129.9	N/A
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	Negative Multiple: -95	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

-5.2

2-Years Forward

P/E

-9.8

3-Years Forward

P/E

N/A

Pharnext SCA
OTC:PNEXF

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Pharnext SCA OTC:PNEXF

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Pharnext SCA
OTC:PNEXF

P/E
Price to Earnings